Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Peloquin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|May 14, 2021
Response to: 'Correspondence on 'Warfarin use and risk of knee and hip replacements'' by Cheng and ZhangTuhina Neogi, Christine Peloquin, Priyanka Ballal, et al.
Clinical Rheumatology|September 11, 2025
Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritisAngela Achkar, Christine Peloquin, Jean W Liew, et al.
Annals of the Rheumatic Diseases|August 11, 2021
Warfarin use and risk of knee and hip replacementsPriyanka Ballal, Christine Peloquin, Cindy Germaine Boer, et al.
The Journal of Rheumatology|March 3, 2017
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort StudyJosefina Durán, Christine Peloquin, Yuqing Zhang, et al.
Annals of the Rheumatic Diseases|June 8, 2021
Response to: 'Correspondence on: 'Warfarin use and risk of knee and hip replacements'' by He <i>et al</i>Priyanka Ballal, Christine Peloquin, Cindy Germaine Boer, et al.
Annals of the Rheumatic Diseases|October 9, 2017
Effect of bisphosphonates on knee replacement surgeryTuhina Neogi, Shanshan Li, Christine Peloquin, et al.
Annals of the Rheumatic Diseases|February 16, 2018
Response to: 'Bisphosphonates reduce the risk of knee replacement: we need more analyses!' by Li <i>et al</i>Tuhina Neogi, Shanshan Li, Christine Peloquin, et al.
Annals of the Rheumatic Diseases|January 31, 2018
Response to: 'Association between bisphosphonate use and risk of undergoing knee replacement in osteoarthritis patients' by Chen <i>et al</i>Tuhina Neogi, Shanshan Sheehy, Christine Peloquin, et al.
BMC Rheumatology|July 29, 2021
Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control studyRachael Stovall, Christine Peloquin, David Felson, et al.
The Journal of Rheumatology|January 16, 2021
Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee ArthroplastyRachael Stovall, Christine Peloquin, David Felson, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|May 14, 2021
Response to: 'Correspondence on 'Warfarin use and risk of knee and hip replacements'' by Cheng and ZhangTuhina Neogi, Christine Peloquin, Priyanka Ballal, et al.
Clinical Rheumatology|September 11, 2025
Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritisAngela Achkar, Christine Peloquin, Jean W Liew, et al.
Annals of the Rheumatic Diseases|August 11, 2021
Warfarin use and risk of knee and hip replacementsPriyanka Ballal, Christine Peloquin, Cindy Germaine Boer, et al.
The Journal of Rheumatology|March 3, 2017
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort StudyJosefina Durán, Christine Peloquin, Yuqing Zhang, et al.
Annals of the Rheumatic Diseases|June 8, 2021
Response to: 'Correspondence on: 'Warfarin use and risk of knee and hip replacements'' by He <i>et al</i>Priyanka Ballal, Christine Peloquin, Cindy Germaine Boer, et al.
Annals of the Rheumatic Diseases|October 9, 2017
Effect of bisphosphonates on knee replacement surgeryTuhina Neogi, Shanshan Li, Christine Peloquin, et al.
Annals of the Rheumatic Diseases|February 16, 2018
Response to: 'Bisphosphonates reduce the risk of knee replacement: we need more analyses!' by Li <i>et al</i>Tuhina Neogi, Shanshan Li, Christine Peloquin, et al.
Annals of the Rheumatic Diseases|January 31, 2018
Response to: 'Association between bisphosphonate use and risk of undergoing knee replacement in osteoarthritis patients' by Chen <i>et al</i>Tuhina Neogi, Shanshan Sheehy, Christine Peloquin, et al.
BMC Rheumatology|July 29, 2021
Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control studyRachael Stovall, Christine Peloquin, David Felson, et al.
The Journal of Rheumatology|January 16, 2021
Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee ArthroplastyRachael Stovall, Christine Peloquin, David Felson, et al.
Pageof 3